AAAAAA

   
Results: 1-10 |
Results: 10
CD34 AUGMENTATION IMPROVES ALLOGENEIC T-CELL-DEPLETED BONE-MARROW ENGRAFTMENT
Authors: NOGA SJ SEBER A DAVIS JM BERENSON RJ VOGELSANG GB BRAINE HG HESS AD MARCELLUS D MILLER CA SHARKIS SJ GOODMAN SN SANTOS GW JONES RJ
Citation: Sj. Noga et al., CD34 AUGMENTATION IMPROVES ALLOGENEIC T-CELL-DEPLETED BONE-MARROW ENGRAFTMENT, Journal of hematotherapy, 7(2), 1998, pp. 151-157
PSYCHOLOGICAL DISTRESS AMONG ADULT PATIENTS BEING EVALUATED FOR BONE-MARROW TRANSPLANTATION
Authors: BAKER F MARCELLUS D ZABORA J POLLAND A JODREY D
Citation: F. Baker et al., PSYCHOLOGICAL DISTRESS AMONG ADULT PATIENTS BEING EVALUATED FOR BONE-MARROW TRANSPLANTATION, Psychosomatics, 38(1), 1997, pp. 10-19
USING ENGINEERED ALLOGRAFTS TO IMPROVE TRANSPLANT OUTCOME IN MULTIPLE-MYELOMA (MM)
Authors: NOGA SJ ODONNELL PV GREVER M VOGELSANG GB MARCELLUS D JONES RJ
Citation: Sj. Noga et al., USING ENGINEERED ALLOGRAFTS TO IMPROVE TRANSPLANT OUTCOME IN MULTIPLE-MYELOMA (MM), Blood, 90(10), 1997, pp. 992-992
FLUDARABINE AND CYCLOPHOSPHAMIDE AS FIRST THERAPY FOR INDOLENT LYMPHOPROLIFERATIVE DISORDERS - RESPONSE RATES AND TOXICITY
Authors: FLINN IW BYRD JC SEIFTER E MARCELLUS D LEE N DIEHL LF AMBINDER RF GREVER MR VOGELSANG G
Citation: Iw. Flinn et al., FLUDARABINE AND CYCLOPHOSPHAMIDE AS FIRST THERAPY FOR INDOLENT LYMPHOPROLIFERATIVE DISORDERS - RESPONSE RATES AND TOXICITY, Blood, 88(10), 1996, pp. 2345-2345
QUALITY-OF-LIFE AND SOCIAL SUPPORT OF PATIENTS BEING EVALUATED FOR BONE-MARROW TRANSPLANTATION
Authors: BAKER F ZABORA J JODREY D POLLAND A MARCELLUS D
Citation: F. Baker et al., QUALITY-OF-LIFE AND SOCIAL SUPPORT OF PATIENTS BEING EVALUATED FOR BONE-MARROW TRANSPLANTATION, Journal of clinical psychology in medical settings, 2(4), 1995, pp. 357-372
CHANGES IN QUALITY-OF-LIFE DURING THE FIRST YEAR AFTER BONE-MARROW TRANSPLANTATION - A PROSPECTIVE-STUDY
Authors: BAKER F ZABORA J JODREY D MARCELLUS D POLLAND A WINGARD J
Citation: F. Baker et al., CHANGES IN QUALITY-OF-LIFE DURING THE FIRST YEAR AFTER BONE-MARROW TRANSPLANTATION - A PROSPECTIVE-STUDY, Blood, 86(10), 1995, pp. 1582-1582
LOW-RISK OF EPSTEIN-BARR-VIRUS (EBV)-ASSOCIATED POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE (PTLD) IN PATIENTS RECEIVING ELUTRIATED ALLOGENEIC MARROW TRANSPLANTS MAY REFLECT DEPLETION OF EBV INFECTED LYMPHOCYTES FROM THE GRAFT
Authors: FLINN I ORENTAS R NOGA SJ MARCELLUS D VOGELSAND GB JONES RJ AMBINDER RF
Citation: I. Flinn et al., LOW-RISK OF EPSTEIN-BARR-VIRUS (EBV)-ASSOCIATED POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE (PTLD) IN PATIENTS RECEIVING ELUTRIATED ALLOGENEIC MARROW TRANSPLANTS MAY REFLECT DEPLETION OF EBV INFECTED LYMPHOCYTES FROM THE GRAFT, Blood, 86(10), 1995, pp. 2490-2490
COMPARISON OF THE ADDITION OF T-INTEGER AND N-INTEGER SCORES WITH TNMSTAGE GROUPS IN HEAD AND NECK-CANCER
Authors: JONES GW BROWMAN G GOODYEAR M MARCELLUS D HODSON DI
Citation: Gw. Jones et al., COMPARISON OF THE ADDITION OF T-INTEGER AND N-INTEGER SCORES WITH TNMSTAGE GROUPS IN HEAD AND NECK-CANCER, Head & neck, 15(6), 1993, pp. 497-503
ADJUVANT RADIOTHERAPY FOR EARLY BREAST-CANCER - PATTERNS OF PRACTICE IN ONTARIO
Authors: WHELAN T MARCELLUS D CLARK R LEVINE M
Citation: T. Whelan et al., ADJUVANT RADIOTHERAPY FOR EARLY BREAST-CANCER - PATTERNS OF PRACTICE IN ONTARIO, CMAJ. Canadian Medical Association journal, 149(9), 1993, pp. 1273-1277
EXPLOSIVE GRAFT-VERSUS-HOST DISEASE
Authors: VOGELSANG GB ALTOMONTE V FARMER E HORN T MARCELLUS D SANTOS GW
Citation: Gb. Vogelsang et al., EXPLOSIVE GRAFT-VERSUS-HOST DISEASE, Blood, 82(10), 1993, pp. 10000422-10000422
Risultati: 1-10 |